Allogene Therapeutics (ALLO) announced an update on their ongoing clinical study. The ALPHA study, officially titled A Single-Arm, Open-Label, Phase 1 Study Evaluating the Safety, Efficacy, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback